Samir Ramakant Dave Acquires 5.66% Stake in Chandra Bhagat Pharma
Chandra Bhagat Pharma Ltd 路 Acquisition/ Disposal of Shares 路 27 Oct 2026, 4:27 pm
Samir Ramakant Dave Acquires 5.66% Stake in Chandra Bhagat Pharma Samir Ramakant Dave acquired 8,00,000 convertible warrants in Chandra Bhagat Pharma Limited via a preferential issue allotted on 22nd Oct'26. The acquisition represents 5.66% of the company's total diluted share and voting capital post-conversion. Prior to this allotment, the acquirer held nil shares. Following the preferential issue and assuming full warrant conversion, Chandra Bhagat Pharma's total diluted equity base expands from 75,45,056 shares to 1,41,45,056 equity shares of face value Rs. 10 each.
Original exchange filing (PDF)
More announcements from Chandra Bhagat Pharma Ltd
- Outcome of the Board Meeting held on 13th November, 2026. 路 13 Nov 2026
- Outcome of the Board Meeting held on 13th November, 2026 for approval of un-audited result as on 30th September, 2026. 路 13 Nov 2026
- Chandra Bhagat Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Un-audited Result for .... 路 13 Nov 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chintan Vijay Makhecha 路 27 Oct 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hemant Chandravadan Bhagat & PACs 路 26 Oct 2026
- Please find attached disclosure under Reg 30 of SEBI (LODR) Regulations, 2015 for your reference. 路 22 Oct 2026
- Certificate for Non_Applicability of Corporate Governance Certificate for the quarter ended 30th September, 2026. 路 21 Oct 2026
- The Company has informed the stock exchange regarding receipt of In-Principle approval for issue of shares on preferential basis. 路 13 Oct 2026
